TELA Bio, a medical technology company specializing in soft-tissue reconstruction, announced it will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The presentation will be available via live and archived webcast, providing investors insight into the company's innovations and business progress. This event is an opportunity for TELA Bio to showcase its commitment to advancing soft-tissue reconstruction solutions that leverage natural healing. Investors and interested parties can access the webcast through the company's investor relations website.
Ed Stafford, famed explorer and Discovery Channel host, has become a global owner of the JETOUR G700 SUV, marking a partnership to co-produce Season 2 of JETOUR’s Adventure of Extremes. The vehicle handover ceremony was held with top executives from ...
XRP holders can borrow Ripple's RLUSD stablecoin on Ethereum by using wrapped XRP (FXRP) as collateral through a $280 million lending pool managed by Sentora. This new isolated market on Morpho Blue allows borrowing without selling XRP, with FXRP app...
Prologis has agreed to acquire SEGRO for approximately $18.8 billion, combining two major logistics portfolios to create a global platform with $269 billion in assets. The deal will expand Prologis' European footprint by 47%, adding 368 million squar...
AudioCodes reported a 3.1% year-over-year revenue increase to $63 million in Q2 2026, led by a 6.2% rise in services revenue and strong growth in its Voice AI business, which expanded over 50%. The company achieved a GAAP net income of $0.5 million a...
Equinor ASA has repurchased 660,000 of its own shares at an average price of NOK 382.24 per share from July 27 to July 31, 2026, as part of the third tranche of its 2026 share buy-back program. This tranche, announced on July 22, 2026, runs until Oct...
